RhumbLine Advisers
NUTX

RhumbLine Advisers’s Nutex Health NUTX Stock Holding History

RhumbLine Advisers’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.02M Buy
5,982
+287
+5% +$36.4K ﹤0.01% 2302
2026
Q1 		$541K Buy
5,695
+1,536
+37% +$188K ﹤0.01% 2559
2025
Q4 		$685K Sell
4,159
-740
-15% -$98.2K ﹤0.01% 2457
2025
Q3 		$506K Sell
4,899
-133
-3% -$13K ﹤0.01% 2692
2025
Q2 		$626K Buy
5,032
+4,935
+5,088% +$637K ﹤0.01% 2537
2025
Q1 		$4.56K Hold
97
– – ﹤0.01% 3917
2024
Q4 		$3.07K Hold
97
– – ﹤0.01% 4002
2024
Q3 		$2.1K Sell
97
-1
-1% -$14 ﹤0.01% 4053
2024
Q2 		$580 Hold
98
– – ﹤0.01% 4281
2024
Q1 		$1.41K Hold
98
– – ﹤0.01% 4118
2023
Q4 		$2.63K Hold
98
– – ﹤0.01% 4067
2023
Q3 		$2.97K Sell
98
-99
-50% -$4.78K ﹤0.01% 4066
2023
Q2 		$12.5K Sell
197
-1,373
-87% -$118K ﹤0.01% 3898
2023
Q1 		$238K Sell
1,570
-54
-3% -$10.9K ﹤0.01% 2694
2022
Q4 		$463K Buy
1,624
+1,222
+304% +$235K ﹤0.01% 2497
2022
Q3 		$90K Buy
402
+119
+42% +$50.5K ﹤0.01% 3009
2022
Q2 		$137K Buy
+283
New +$334K ﹤0.01% 3004

Other funds holding NUTX

PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Winmill & Co Walpole, New Hampshire $452M AUM 56.84% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

RhumbLine Advisers's NUTX Position: Q2 2026 in Review

RhumbLine Advisers increased its Nutex Health (NUTX) stake by 5% in Q2 2026, buying an estimated $36.4K and bringing the position to 5,982 shares worth $1.02M. The position accounts for ﹤0.01% of the portfolio, ranked #2302.

RhumbLine Advisers first reported a position in NUTX in Q2 2022 and has held it in 17 quarters since. 154 funds tracked by Wall St. Rank hold NUTX as of Q2 2026.

  • RhumbLine Advisers held 5,982 shares of Nutex Health worth $1.02M as of Q2 2026.
  • RhumbLine Advisers bought 287 Nutex Health shares in Q2 2026, an estimated $36.4K.
  • Nutex Health made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #2302 holding.
  • RhumbLine Advisers first reported a position in Nutex Health in Q2 2022 and has held it in 17 quarters since.
  • 154 funds tracked by Wall St. Rank held Nutex Health as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.